FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114285855> ?p ?o ?g. }

• W3114285855 endingPage "111" @default.
• W3114285855 startingPage "102" @default.
• W3114285855 abstract "Background CDKN2A is a tumor suppressor gene that encodes the cell cycle inhibitor protein p16. Homozygous deletion of the CDK-N2A gene has been associated with shortened survival in isocitrate dehydrogenase (IDH)–mutant gliomas. This study aimed to analyze the prognostic value of p16 and to evaluate whether p16 immunohistochemical staining could be used as a prognostic marker to replace CDKN2A genotyping in diffuse gliomas. Methods p16 immunohistochemistry was performed on tissue microarrays of 326 diffuse gliomas with diagnoses that reflected IDH-mutations and 1p/19q codeletion status. The results were divided into three groups (negative, focal expression, overexpression) according to the presence and degree of p16 expression. Survival analysis was performed to assess the prognostic value of p16 expression. Results A loss of p16 expression predicted a significantly worse outcome in all glioma patients (n = 326, p < .001), in the IDH-mutant glioma patients (n = 103, p = .010), and in the IDH-mutant astrocytoma patients (n = 73, p = .032). However, loss of p16 expression did not predict the outcome in the IDH-wildtype glioma patients (n = 223, p = .121) or in the oligodendroglial tumor patients with the IDH-mutation and 1p/19q codeletion (n = 30, p = .457). Multivariate analysis showed the association was still significant in the IDH-mutant glioma patients (p = .008; hazard ratio [HR], 2.637; 95% confidence interval [CI], 1.295 to 5.372) and in the IDH-mutant astrocytoma patients (p = .001; HR, 3.586; 95% CI, 1.649 to 7.801). Interestingly, patients who presented with tumors with p16 overexpression also had shorter survival times than did patients with tumors with p16 focal expression in the whole glioma (p < .001) and in IDH-mutant glioma groups. (p = .046). Conclusions This study suggests that detection of p16 expression by immunohistochemistry can be used as a useful surrogate test to predict prognosis, especially in IDH-mutant astrocytoma patients. Key words: Glioma; p16; Immunohistochemistry; Prognosis; CDKN2A" @default.
• W3114285855 created "2021-01-05" @default.
• W3114285855 creator A5005523057 @default.
• W3114285855 creator A5011931629 @default.
• W3114285855 creator A5027126871 @default.
• W3114285855 creator A5028959139 @default.
• W3114285855 creator A5070033243 @default.
• W3114285855 creator A5080537858 @default.
• W3114285855 creator A5087650357 @default.
• W3114285855 date "2021-03-15" @default.
• W3114285855 modified "2023-09-30" @default.
• W3114285855 title "The prognostic significance of p16 expression pattern in diffuse gliomas" @default.
• W3114285855 cites W115918952 @default.
• W3114285855 cites W1514125758 @default.
• W3114285855 cites W1533669050 @default.
• W3114285855 cites W1592215560 @default.
• W3114285855 cites W1966135244 @default.
• W3114285855 cites W1976956469 @default.
• W3114285855 cites W2016086666 @default.
• W3114285855 cites W2018330147 @default.
• W3114285855 cites W2018560565 @default.
• W3114285855 cites W2025120938 @default.
• W3114285855 cites W2028906953 @default.
• W3114285855 cites W2038079389 @default.
• W3114285855 cites W2040616051 @default.
• W3114285855 cites W2057471016 @default.
• W3114285855 cites W2066503677 @default.
• W3114285855 cites W2074730382 @default.
• W3114285855 cites W2077536614 @default.
• W3114285855 cites W2088764292 @default.
• W3114285855 cites W2095826251 @default.
• W3114285855 cites W2101940777 @default.
• W3114285855 cites W2105528101 @default.
• W3114285855 cites W2137600380 @default.
• W3114285855 cites W2153913749 @default.
• W3114285855 cites W2165354014 @default.
• W3114285855 cites W2385742736 @default.
• W3114285855 cites W2410566185 @default.
• W3114285855 cites W2739147644 @default.
• W3114285855 cites W2758448576 @default.
• W3114285855 cites W2802818144 @default.
• W3114285855 cites W2984912591 @default.
• W3114285855 cites W3003863259 @default.
• W3114285855 cites W3016756297 @default.
• W3114285855 cites W3023953516 @default.
• W3114285855 cites W307329015 @default.
• W3114285855 doi "https://doi.org/10.4132/jptm.2020.10.22" @default.
• W3114285855 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7987518" @default.
• W3114285855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33348944" @default.
• W3114285855 hasPublicationYear "2021" @default.
• W3114285855 type Work @default.
• W3114285855 sameAs 3114285855 @default.
• W3114285855 citedByCount "11" @default.
• W3114285855 countsByYear W31142858552021 @default.
• W3114285855 countsByYear W31142858552022 @default.
• W3114285855 countsByYear W31142858552023 @default.
• W3114285855 crossrefType "journal-article" @default.
• W3114285855 hasAuthorship W3114285855A5005523057 @default.
• W3114285855 hasAuthorship W3114285855A5011931629 @default.
• W3114285855 hasAuthorship W3114285855A5027126871 @default.
• W3114285855 hasAuthorship W3114285855A5028959139 @default.
• W3114285855 hasAuthorship W3114285855A5070033243 @default.
• W3114285855 hasAuthorship W3114285855A5080537858 @default.
• W3114285855 hasAuthorship W3114285855A5087650357 @default.
• W3114285855 hasBestOaLocation W31142858551 @default.
• W3114285855 hasConcept C104317684 @default.
• W3114285855 hasConcept C121608353 @default.
• W3114285855 hasConcept C126322002 @default.
• W3114285855 hasConcept C127848430 @default.
• W3114285855 hasConcept C142724271 @default.
• W3114285855 hasConcept C143065580 @default.
• W3114285855 hasConcept C143998085 @default.
• W3114285855 hasConcept C181199279 @default.
• W3114285855 hasConcept C193270364 @default.
• W3114285855 hasConcept C204232928 @default.
• W3114285855 hasConcept C207103383 @default.
• W3114285855 hasConcept C2777150147 @default.
• W3114285855 hasConcept C2778227246 @default.
• W3114285855 hasConcept C2778880634 @default.
• W3114285855 hasConcept C2780265364 @default.
• W3114285855 hasConcept C44249647 @default.
• W3114285855 hasConcept C502942594 @default.
• W3114285855 hasConcept C55493867 @default.
• W3114285855 hasConcept C71924100 @default.
• W3114285855 hasConcept C86803240 @default.
• W3114285855 hasConceptScore W3114285855C104317684 @default.
• W3114285855 hasConceptScore W3114285855C121608353 @default.
• W3114285855 hasConceptScore W3114285855C126322002 @default.
• W3114285855 hasConceptScore W3114285855C127848430 @default.
• W3114285855 hasConceptScore W3114285855C142724271 @default.
• W3114285855 hasConceptScore W3114285855C143065580 @default.
• W3114285855 hasConceptScore W3114285855C143998085 @default.
• W3114285855 hasConceptScore W3114285855C181199279 @default.
• W3114285855 hasConceptScore W3114285855C193270364 @default.
• W3114285855 hasConceptScore W3114285855C204232928 @default.
• W3114285855 hasConceptScore W3114285855C207103383 @default.
• W3114285855 hasConceptScore W3114285855C2777150147 @default.
• W3114285855 hasConceptScore W3114285855C2778227246 @default.

• next